| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.45 | 0.007 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |